Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome
- 21 Downloads
To evaluate the mid-term outcome of salvage radiofrequency ablation (RFA) treatment in patients who exhibited intrahepatic recurrence after major hepatectomy for colorectal liver metastases (CRCLM).
Observational study on 23 consecutive patients (mean age 59 ± 9 years; 14/9 male/female) who, after a single (11/23) or multiple rounds (12/23) of major hepatic surgery, developed recurrent CRCLM in the liver remnant. Patients with a maximum of three metastases measuring up to 3 cm, and without relevant extrahepatic disease, underwent CT-guided RFA. Using the Kaplan-Meier-method, median intrahepatic progression-free-survival (ihPFS) and overall survival (OS) times after salvage RFA were compared with the same patients’ time between the respective last round of surgery and diagnosis of intrahepatic recurrence leading to RFA.
Median follow-up was 26 months (range 12–103 months). Median ihPFS time after RFA was 8 months (range 1–81 months). Median ihPFS time after the respective last round of surgery and RFA in the same patients had been 5 months (range 1–23 months), thus yielding similar ihPFS times after surgery vs. after salvage RFA (p = 0.238; Mood’s median test). After RFA, 15/23 (65%) of patients developed new hepatic metastases within the first year post-RFA. Median OS was 37 months, with a 1-year OS rate of 100%, 3-year OS rate of 57%, and 5-year OS rate of 24%. No major complications were observed.
Patients who exhibit intrahepatic recurrence of CRCLM after major hepatectomy will experience intrahepatic recurrence after salvage RFA as well, and after similar time intervals. However, long-term ihPFS may still be achieved in some patients.
• Patients who exhibit intrahepatic recurrence of colorectal liver metastases after major hepatectomy will experience intrahepatic recurrence after salvage RFA as well, and after similar time intervals.
• About two-thirds of all patients develop new metastases elsewhere in the liver within 1 year after RFA.
• However, long-term intrahepatic progression-free survival may still be achieved in some patients.
KeywordsRadiofrequency ablation Hepatectomy Colorectal neoplasms Survival analysis
Abbreviations and acronyms
Colorectal liver metastases
Intrahepatic progression-free survival
The authors state that this work has not received any funding.
Compliance with ethical standards
The scientific guarantor of this publication is Prof. Philipp Bruners.
Conflict of interest
The authors declare that they have no conflict of interest.
Statistics and biometry
The Institute of Medical Statistics of the University Hospital RWTH Aachen kindly provided statistical advice for this manuscript.
Written informed consent was waived by the Institutional Review Board.
Institutional Review Board approval was obtained.
• performed at one institution
- 2.Mantke R, Schmidt U, Wolff S, Kube R, Lippert H (2012) Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study. Eur J Surg Oncol 38:259–265CrossRefGoogle Scholar
- 17.de Jong MC, Pulitano C, Ribero D et al (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250:440–448Google Scholar
- 18.Ruers T, Van Coevorden F, Punt CJ et al (2017) Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst 109Google Scholar